Read More

LimFlow Announces Agreement To Be Acquired by Inari Medical; LimFlow Will Receive $250M In Cash At Closing And Be Eligible To Receive Up To $165M In Additional Payments Based On Certain Commercial And Reimbursement Milestones Total Value Of $415M

LimFlow SA, a pioneer in the development of minimally-invasive technology for the treatment of chronic limb-threatening ischemia (CLTI), a severe form of peripheral artery disease (PAD), announced today that it has

NARI